- Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
-
Suzuki H, Tsutsumi T, Kawaguchi M, Amano K, Kawaguchi T
- KMID: 2557402
- Clin Mol Hepatol.
- 2024 Jul;30(3):577-579.
- doi: 10.3350/cmh.2024.0157
-
- CITED
-
- Close
- SHARE
-
- Close
- Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
-
Suzuki H, Tsutsumi T, Kawaguchi M, Amano K, Kawaguchi T
- KMID: 2560097
- Clin Mol Hepatol.
- 2024 Oct;30(4):962-964.
- doi: 10.3350/cmh.2024.0264
-
- CITED
-
- Close
- SHARE
-
- Close
- Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
-
Nakamura T, Nakano M, Tsutsumi T, Amano K, Kawaguchi T
- KMID: 2560076
- Clin Mol Hepatol.
- 2024 Oct;30(4):705-708.
- doi: 10.3350/cmh.2024.0372
-
- CITED
-
- Close
- SHARE
-
- Close
- Open Abdominal Management Among Non-Trauma Patients: The Appropriate Duration and a New Clinical Index
-
Inukai K, Usui A, Hashimoto Y, Kato F, Amano K, Kayata H, Mukai N, Shinyama N
- KMID: 2536163
- J Acute Care Surg.
- 2022 Nov;12(3):97-102.
- doi: 10.17479/jacs.2022.12.3.97
Purpose: Despite widespread adoption of open abdominal management (OAM), there is currently no threshold criterion for OAM duration for non-trauma patients. Moreover, there is a positive relationship between morbidity and... -
- CITED
-
- Close
- SHARE
-
- Close
